Schoch Charles

Candel Therapeutics, Inc. · Chief Financial Officer

Schoch Charles is listed in public filings as officer: Chief Financial Officer. This Schoch Charles insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Candel Therapeutics, Inc. (CADL). Investors use Schoch Charles's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Candel Therapeutics, Inc.CADL$1.4M232k sharesGrant / ExerciseJan 26, 2026$1.4M232k shares$6.01--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Candel Therapeutics, Inc.CADL$203k43.4k sharesGrant / ExerciseJun 25, 2025$25.0K5.4k shares$4.67--
Candel Therapeutics, Inc.CADL$238k50k sharesGrant / ExerciseJun 20, 2025$237.5K50k shares$4.75--
Candel Therapeutics, Inc.CADL$336k38k sharesSellMar 17, 2025$44.2K5k shares$8.83--
Candel Therapeutics, Inc.CADL$710k83k sharesGrant / ExerciseFeb 12, 2025$709.6K83k shares$8.55--
Candel Therapeutics, Inc.CADL$311k43k sharesSellJan 15, 2025$68.7K9.5k shares$7.23--
Candel Therapeutics, Inc.CADL$432k52.5k sharesSellJan 8, 2025$81.9K10k shares$8.22--
Candel Therapeutics, Inc.CADL$405k62.5k sharesSellJul 17, 2024$64.0K9.9k shares$6.47--
Candel Therapeutics, Inc.CADL$432k72.4k sharesSellJul 11, 2024$53.1K8.9k shares$5.97--